Eye Exercise, Transcutaneous Electrical Nerve Stimulation on Prevention of Myopia Progression
NCT ID: NCT04017234
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
27 participants
INTERVENTIONAL
2019-09-10
2020-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eye Drops Study for Myopia Control in Schoolchildren
NCT03402100
Clinical Study of Light Therapy to Control Myopia Progression in Children
NCT05761379
Red Light Intervention on Myopic Progression
NCT05203432
Efficacy of Chinese Ocular Exercise on Visual Acuity and Ocular Accommodation in Myopic Teenager
NCT01756287
The Efficacy and Safety of Periocular Acupoint Stimulation on Myopia Progression in Children
NCT02064660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators will apply the frequency following response, eye exercise, and transcutaneous electrical nerve stimulation on PMP among Taiwan schoolchildren. The findings of the study may provide information for promotion of visual health for schoolchildren and their parents.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PMP group
children received health education for eye and the intervention(which included frequency following response, eye exercise, and transcutaneous electrical nerve stimulation) a 30 minute three times per week for four weeks.
frequency following response, eye exercise, and transcutaneous
frequency following response, eye exercise, and TENS for 3 times per week during 4 weeks
control group
children just received health education for eye
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
frequency following response, eye exercise, and transcutaneous
frequency following response, eye exercise, and TENS for 3 times per week during 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* do not use cyclogel or atropine
* At least the eye ointment is deactivated for at least seven days
* no plastic tablets are currently used
* at least the plastic tablets are not allowed to be retired for more than seven days
Exclusion Criteria
6 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu-Kuei Teng
Role: PRINCIPAL_INVESTIGATOR
China Medical University, Taiwan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chen Pin elementary school
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMUH107-REC1-124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.